13 Stocks Jim Cramer Talked About

8. CVS Health Corporation (NYSE:CVS)

Number of Hedge Fund Holdings: 78

CVS Health Corporation (NYSE:CVS) is one of the largest pharmaceutical retailers in America. Its shares are up by 19.2% over the past year and are down by 2% year-to-date. In late January, Argus trimmed the firm’s share price target to $90 from $91 and kept a Buy rating on the shares. The financial firm pointed out that CVS Health Corporation (NYSE:CVS) would likely weather most of the impact from Medicare and Medicaid reimbursement rates remaining flat, particularly due to its diversified business model. In late January, Bank of America had cut CVS Health Corporation (NYSE:CVS)’s share price target to $95 from $100 and kept a Buy rating on the back of recent news in the Medicare and Medicaid sector. While analysts continue to discuss Medicare and Medicaid when it comes to CVS Health Corporation (NYSE:CVS), Cramer believes that developments in the pharmaceutical retail industry are beneficial for the firm:

“I think David Joiner is going to do well for CVS. Because, CVS is now the front of the store, it’s up against a decimated Wallgreens. A completely absent Rite Aid. And they’ve got a lot of great things in the back, and they’ve got, Aetna’s got a good plan. I bet you that’s the only one that comes out of this thing whole. Yeah, 11 times earnings, I like that. They report next week.”